“B cell lymphomas”的搜索结果，显示 11-20 项，共有 6523 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... lymphoma. Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...

9. CAR-T 细胞疗法计划- 临床试验- 妙佑医疗国际

   The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment of B cell ...

10. 血液科- 临床试验- 妙佑医疗国际

    ... B-Cell Lymphoma (DLBCL). A Study of Hematopoiesis in Patients with Monoclonal B Cell Lymphocytosis (MBL), B-Chronic Lymphocytic Leukemia (CLL), and Healthy ...